The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Antidepressants for cocaine dependence
de Lima, M. S., Farrell, M., Reisser, A. A. L., & Soares, B. G. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002950 · Cited by 80
RetractedCarbamazepine for cocaine dependence
Reisser, A. A. L., Lima, M., Soares, B., & Farrell, M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002023 · Cited by 45
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5485 · Cited by 10,169
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 987
The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome
Ball, J. C., & Ross, A. O. (1991) · Cited by 903
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
The pharmacology of cocaine related to its abuse.
Johanson, C. E., & Fischman, M. W. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00022-5 · Cited by 686
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565
A behavioral approach to achieving initial cocaine abstinence
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1218 · Cited by 550
ENHANCEMENT OF HUMAN PERFORMANCE BY CAFFEINE AND THE AMPHETAMINES
WEISS, B., & LATIES, V. G. (1962) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07003-6 · Cited by 443
Mello, N. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00274-h · Cited by 392
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram
Carroll, K. M., Nich, C., Ball, S. A., Mccance, E., & Rounsavile, B. J. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357137.x · Cited by 375
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R., Kimber, J., Breen, C., & Davoli, M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub2 · Cited by 360
Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030013002 · Cited by 348
Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Fiore, M. C., & Staff, G. P. A. (2000) · Respiratory Care · doi:10.1177/002013240004501007 · Cited by 346
DOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Schubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
Self-citationA National 5-Year Follow-up of Treatment Outcomes for Cocaine Dependence
Simpson, D. D., Joe, G. W., & Broome, K. M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.538 · Cited by 243
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240
Disulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 228
Opium, Cocaine and Marijuana in American History
Musto, D. F. (1991) · Scientific American · doi:10.1038/scientificamerican0791-40 · Cited by 218
Shoptaw, S., Yang, X., Rotheram-Fuller, E. J., Hsieh, Y.-C. M., Kintaudi, P. C., Charuvastra, V. C., & Ling, W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1207 · Cited by 215
Silverman, K., Chutuape, M. A., Bigelow, G. E., & Stitzer, M. L. (1999) · Psychopharmacology · doi:10.1007/s002130051098 · Cited by 212
Stevens Negus, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300096 · Cited by 203
Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects
Carroll, F. I., Howell, L. L., & Kuhar, M. J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9706729 · Cited by 203
Human therapeutic cocaine vaccine: safety and immunogenicity
Kosten, T. R., Rosen, M., Bond, J., Settles, M., Roberts, J. S. C., Shields, J., Jack, L., & Fox, B. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00425-x · Cited by 193
Replacement Medication for Cocaine Dependence: Methylphenidate
Grabowski, J., Roache, J. D., Schmitz, J. M., Rhoades, H., Creson, D., & Korszun, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00008 · Cited by 191
Self-citationModafinil and cocaine: a double-blind, placebo-controlled drug interaction study
Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J. W., Rowan, A., Poole, S., White, L., & O'Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00335-6 · Cited by 186
Haney, M., Ward, A., Foltin, R., & Fischman, M. (2001) · Psychopharmacology · doi:10.1007/s002130100725 · Cited by 186
Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185
Self-citationPharmacological treatment of cocaine dependence: a systematic review
Lima, M. S. D., Soares, B. G. D. O., Reisser, A. A. P., & Farrell, M. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00209.x · Cited by 178
Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys
Negus, S. S., Mello, N. K., Portoghese, P. S., & Lin, C.-E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36769-2 · Cited by 167
Self-citationFederal Regulation of Methadone Treatment
Rettig, R. A., & Yarmolinsky, A. (2013) · Cited by 165
Rothman, R. B., & Glowa, J. R. (1995) · Molecular Neurobiology · doi:10.1007/bf02740680 · Cited by 164
Levin, F. R., Evans, S. M., McDowell, D. M., & Kleber, H. D. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0605 · Cited by 161
George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R., & Schottenfeld, R. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00310-8 · Cited by 159
Cocaine use by clients in methadone programs: Significance, scope, and behavioral interventions
Condelli, W. S., Fairbank, J. A., Dennis, M. L., & Rachal, J. V. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90040-h · Cited by 155
Grabowski, J. G., Rhoades, H. M., Elk, R., Schmitz, J. M., Davis, C., Creson, D., & Kirby, K. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00004 · Cited by 155
Self-citationJaffe, A. J., Rounsaville, B. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & O'Malley, S. S. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.5.1044 · Cited by 149
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Mello, N. K., & Negus, S. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06678.x · Cited by 145
Self-citationPilot randomized double blind placebo‐controlled study of dexamphetamine for cocaine dependence
Shearer, J., WODAK, A. D., van Beek, I., Mattick, R. P., & Lewis, J. E. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00447.x · Cited by 142
Self-citationBalster, R. L., & Schuster, C. R. (1973) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(73)90057-9 · Cited by 141
Naltrexone and relapse prevention treatment for cocaine-dependent patients
Schmitz, J. M., Stotts, A. L., Rhoades, H. M., & Grabowski, J. (2001) · Addictive Behaviors · doi:10.1016/s0306-4603(00)00098-8 · Cited by 138
Self-citationOutpatient Treatment of 'Crack' Cocaine Smoking With Flupenthixol Decanoate
Gawin, F. H. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810040028005 · Cited by 128
Mendelson, J. H., Mello, N. K., Sholar, M. B., Siegel, A. J., Kaufman, M. J., Levin, J. M., Renshaw, P. F., & Cohen, B. M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00020-2 · Cited by 122
Negus, S. S., & Mello, N. K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00339-3 · Cited by 121
Self-citationFluoxetine treatment of cocaine-dependent patients with major depressive disorder
Schmitz, J. M., Averill, P. M., Stotts, A. L., Moeller, F. G., Rhoades, H. M., & Grabowski, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00208-8 · Cited by 121
Self-citationMethylphenidate Treatment of Cocaine Abusers without Attention Deficit Disorder: A Negative Report
Gawin, F. H., Riordan, C. E., & Kleber, H. D. (1985) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998509016861 · Cited by 120
Methylphenidate (Ritalin®) treatment of cocaine dependence—A preliminary report
Khantzian, E. J., Gawin, F. H., Kleber, H. D., & Riordan, C. E. (1984) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(84)90033-3 · Cited by 120
Risperidone for the Treatment of Cocaine Dependence: Randomized, Double-Blind Trial
Grabowski, J. G., Rhoades, H. M., Silverman, P. B., Schmitz, J. M., Stotts, A. L., Creson, D., & Bailey, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00003 · Cited by 116
Self-citationHowell, L. L., & Wilcox, K. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29344-7 · Cited by 115
Kollins, S. H. (2003) · PubMed · Cited by 109
Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development
Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1137-8 · Cited by 108
A controlled trial of fluoxetine in crack cocaine dependence
Batki, S. L., Washburn, A. M., Delucchi, K., & Jones, R. T. (1996) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(96)01233-1 · Cited by 106
Serotonergic Attenuation of the Reinforcing and Neurochemical Effects of Cocaine in Squirrel Monkeys
Czoty, P. W., Ginsburg, B. C., & Howell, L. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.831 · Cited by 105
Negus, S. S., & Mello, N. K. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1409-y · Cited by 101
Self-citationEdwards, G. (1976) · Saxon House , Lexington Books · Cited by 101
Plasma levels of d-amphetamine in hyperactive children: Serial behavior and motor responses
Brown, G. L., Hunt, R. D., Ebert, M. H., Bunney, W. E., & Kopin, I. J. (1979) · Psychopharmacology · doi:10.1007/bf00427126 · Cited by 97
Howell, L. L., & Byrd, L. D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20249-x · Cited by 96
Imipramine treatment of cocaine abuse: possible boundaries of efficacy
Nunes, E. V., McGrath, P. J., Quitkin, F. M., Ocepek‐Welikson, K., Stewart, J. W., Koenig, T., Wager, S., & Klein, D. F. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01161-6 · Cited by 95
Discrete-Trial Choice Procedure: Effects of Naloxone and Methadone on Choice between Food and Heroin
Griffiths, R. R., Wurster, R. M., & Brady, J. V. (1975) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06689-x · Cited by 87
Glutamatergic Agents for Cocaine Dependence
Dackis, C. A., & O’Brien, C. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.021 · Cited by 86
Comparison of buprenorphine and methadone effects on opiate self-administration in primates
Mello, N. K., Bree, M. P., & Mendelson, J. H. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33600-1 · Cited by 85
LeSage, M. G., Keyler, D. E., Collins, G., & Pentel, P. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1539-2 · Cited by 83
Nann-Vernotica, E., Donny, E. C., Bigelow, G. E., & WALSH, S. L. (2001) · Psychopharmacology · doi:10.1007/s002130100724 · Cited by 83
Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., Kosten, T. R., & Rounsaville, B. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00032-5 · Cited by 81
Paterson, R. S., Douglas, C. D., Hallmayer, J. F., Hagan, M., & Krupenia, Z. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.00590.x · Cited by 81
A pilot trial of olanzapine for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Sparkman, T., & O’Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00009-7 · Cited by 81
Kleven, M. S., & Woolverton, W. L. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90067-z · Cited by 79
Regulation of nicotine replacement therapies (NRT): a critique of current practice
McNeill, A. D., Foulds, J., & Bates, C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961217575.x · Cited by 79
Emmett‐Oglesby, M. W., Peltier, R., Depoortère, R., Pickering, C. L., Hooper, M. L., Gong, Y. H., & Lane, J. D. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90089-9 · Cited by 75
Oral drug self-administration: an overview of laboratory animal studies
Meisch, R. A. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00149-5 · Cited by 73
Glowa, J. R., Fantegrossi, W. E., Lewis, D. B., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960551t · Cited by 73
The potential of dopamine agonists in drug addiction
George, T. P., Kosten, T. A., & Kosten, T. R. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.4.491 · Cited by 72
A controlled trial of imipramine for the treatment of methamphetamine dependence
Galloway, G. P., Newmeyer, J. A., Knapp, T., Stalcup, S. A., & Smith, D. E. (1996) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(96)00154-7 · Cited by 71
The amphetamine margin in sports.
Laties, V. G., & Weiss, B. (1981) · PubMed · Cited by 64
Patterns of Cocaine Use among Methadone Clients
Strug, D. L., Hunt, D. E., Goldsmith, D. S., Lipton, D. S., & Spunt, B. J. (1985) · International Journal of the Addictions · doi:10.3109/10826088509056357 · Cited by 64
Pharmacologic Treatments for Heroin and Cocaine Dependence
Kleber, H. D. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00552.x · Cited by 63
Dopamine receptor partial agonists could address the duality of cocaine craving
Childress, A. R., & O’Brien, C. P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01422-4 · Cited by 62
Glowa, J. R., Wojnicki, F. H. E., Matecka, D., Rice, K. C., & Rothman, R. B. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.3.3.232 · Cited by 61
Modulation of intravenous cocaine effects by chronic oral cocaine in humans
WALSH, S. L., Haberny, K. A., & Bigelow, G. E. (2000) · Psychopharmacology · doi:10.1007/s002130000439 · Cited by 56
Is the Prescription of Amphetamine Justified as a Harm Reduction Measure?
Fleming, P. M., & Roberts, D. (1994) · Journal of the Royal Society of Health · doi:10.1177/146642409411400303 · Cited by 56
Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work
Hart, C. L., Ward, A. S., Haney, M., Nasser, J. A., & Foltin, R. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1464-4 · Cited by 55
Garcia-Ladona, F. J., & Cox, B. F. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00246.x · Cited by 53
Somoza, E. C., Winhusen, T. M., Bridge, T. P., Rotrosen, J., Vanderburg, D. G., Harrer, J. M., Mezinskis, J. P., Montgomery, M. A., Ciraulo, D. A., Wulsin, L. R., et al. (2004) · Journal of Addictive Diseases · doi:10.1300/j069v23n01_07 · Cited by 53
Flupenthixol Treatment for Cocaine Abusers with Schizophrenia: A Pilot Study
LEVIN, F. R., Evans, S. M., Coomaraswamy, S., Collins, E. D., Regent, N., & Kleber, H. D. (1998) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999809016902 · Cited by 50
A screening trial of amantadine as a medication for cocaine dependence
SHOPTAW, S. J., Kintaudi, P. C., Charuvastra, C., & Ling, W. W. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00205-8 · Cited by 50
Negus, S. S., Mello, N. K., Lamas, X., & Mendelson, J. H. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20676-0 · Cited by 50
Self-citationDexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation
White, R. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522299.x · Cited by 49
Prevalence and demographic factors of stimulant use
Pickering, H., & Stimson, G. V. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03734.x · Cited by 48
Clinical Applications of Modafinil in Stimulant Abusers: Low Abuse Potential
Malcolm, R. J., Book, S. W., Moak, D. H., DeVane, L., & Czepowicz, V. D. (2002) · American Journal on Addictions · doi:10.1080/10550490290088027 · Cited by 47
Mello, N. K., & Negus, S. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37431-2 · Cited by 47
Self-citationPharmacotherapies for problematic psychostimulant use: a review of current research
Shearer, J., & Gowing, L. (2004) · Drug and Alcohol Review · doi:10.1080/09595230410001704190 · Cited by 45
Self-citationEffect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans
Evans, S. M., WALSH, S. L., LEVIN, F. R., Foltin, R. W., Fischman, M. W., & Bigelow, G. E. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00129-6 · Cited by 45
Baumann, M. H., AYESTAS, M. A., Sharpe, L. G., Lewis, D. B., Rice, K. C., & Rothman, R. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1190 · Cited by 44
Charnaud, B., & Griffiths, V. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00052-0 · Cited by 43
Kleven, M. S., & Woolverton, W. L. (1990) · Psychopharmacology · doi:10.1007/bf02244128 · Cited by 42
Appetite Suppressants as Agonist Substitution Therapies for Stimulant Dependence
Rothman, R. B., Blough, B. E., & Baumann, M. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04155.x · Cited by 42
Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2001) · Psychopharmacology · doi:10.1007/s002130100779 · Cited by 40
Lile, J. A., Morgan, D., Birmingham, A. M., Wang, Z., Woolverton, W. L., Davies, H. M. L., & Nader, M. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039180 · Cited by 40
Negus, S. S., Brandt, M. R., & Mello, N. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35071-2 · Cited by 38
Self-citationLaboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment.
Roache, J., Grabowski, J., Schmitz, J. M., Creson, D. L., & Rhoades, H. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00011 · Cited by 38
Self-citationA review of psychosocial interventions for amphetamine use
Baker, A., & Lee, N. (2003) · Drug and Alcohol Review · doi:10.1080/0959523031000154472 · Cited by 37
Wang, N., Brown, V., Grabowski, J., & Meisch, R. A. (2001) · Psychopharmacology · doi:10.1007/s002130100731 · Cited by 36
Self-citationMutschler, N. H., & Bergman, J. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0976-z · Cited by 36
Comparison of Desipramine or Carbamazepine to Placebo for Crack Cocaine‐Dependent Patients
Campbell, J., Nickel, E. J., Penick, E. C., Wallace, D., Gabrielli, W. F., Rowe, C., Liskow, B., Powell, B. J., & Thomas, H. M. (2003) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00610.x · Cited by 36
Substitution therapy for amphetamine users
Shearer, J., Sherman, J. P., WODAK, A. D., & van Beek, I. (2002) · Drug and Alcohol Review · doi:10.1080/09595230220139082 · Cited by 35
Self-citationWojnicki, F. H. E., Rothman, R. B., Rice, K. C., & Glowa, J. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37989-3 · Cited by 35
Desipramine effects on cocaine self-administration by rhesus monkeys
Mello, N. K., Lukas, S. E., Bree, M. P., & Mendelson, J. H. (1990) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(90)90117-w · Cited by 29
Amphetamine Prescribing as a Harm Reduction Measure: A Preliminary Study
McBride, A. J., Sullivan, G., Blewetp, A. E., & Morgan, S. (1997) · Addiction Research & Theory · doi:10.3109/16066359709005253 · Cited by 29
Effects of methadone and morphine maintenance on drug-seeking behavior in the dog
Jones, B. E., & Prada, J. A. (1977) · Psychopharmacology · doi:10.1007/bf00426764 · Cited by 26
Platt, D. M., Rodefer, J. S., Rowlett, J. K., & Spealman, R. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1347-0 · Cited by 26
Research Issues Related to Development of Medications for Treatment of Cocaine Addiction
Klein, M. B. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08223.x · Cited by 25
Kampman, K. M., Rukstalis, M. R., Ehrman, R. N., McGinnis, D. E., Gariti, P., Volpicelli, J. R., Pettinati, H. M., & O’Brien, C. P. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00040-9 · Cited by 24
Glowa, J. R., & Fantegrossi, W. E. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)01350-1 · Cited by 24
The role of endozepine in the regulation of steroid synthesis
Hall, P. F. (1995) · Molecular Neurobiology · doi:10.1007/bf02740835 · Cited by 23
Pharmacological evaluation of narcotic antagonist delivery systems in rhesus monkeys.
Harrigan, S. E., & Downs, D. A. (1981) · PubMed · Cited by 22
Batki, S. L., MOON, J., Delucchi, K., Bradley, M. S., HERSH, D., Smolar, S., Mengis, M. M., LEFKOWITZ, E., SEXE, D., MORELLO, L., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06688.x · Cited by 21
The role of substitute therapy in the treatment of problem amphetamine use
Klee, H., Wright, S., Carnwath, T., & MERRILL, J. (2001) · Drug and Alcohol Review · doi:10.1080/09595230120092715 · Cited by 21
Self-citationAnti-cocaine vaccines: antibody protection against relapse
Kantak, K. M. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.2.213 · Cited by 21
A Review of Pharmacotherapies for Substance Abuse
Kosten, T. R., & McCance, E. F. (1996) · American Journal on Addictions · doi:10.1111/j.1521-0391.1996.tb00284.x · Cited by 21
Baumann, M. H., PHILLIPS, J. M., AYESTAS, M. A., Ali, S. F., Rice, K. C., & Rothman, R. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04154.x · Cited by 20
A pilot programme in prescribing dexamphetamine for amphetamine users (part I)
Pates, R. M., Coombes, N., & Ford, N. (1996) · Journal of Substance Misuse · doi:10.3109/14659899609084975 · Cited by 19
Clinical evaluation of psychotropic drugs
Baldwin, D. S. (2004) · Psychiatry · doi:10.1383/psyt.3.7.14.42876 · Cited by 18
Methodologic Recommendations for Cocaine Abuse Clinical Trials: A Clinician-Researcher's Perspective
Nunes, E. V. (1997) · PsycEXTRA Dataset · doi:10.1037/e495552006-004 · Cited by 18
Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys.
Winger, G. D., & Woods, J. H. (1996) · PubMed · Cited by 17
Pharmacotherapies for cocaine dependence
O’Leary, G., & Weiss, R. D. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0010-x · Cited by 12
Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat
Lukas, S. E., Moreton, J. E., & Khazan, N. (1981) · Psychopharmacology · doi:10.1007/bf00431092 · Cited by 7
Cited by
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 434
SLC6 transporters: Structure, function, regulation, disease association and therapeutics
Pramod, A. B., Foster, J., Carvelli, L., & Henry, L. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.002 · Cited by 319
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270
Drug policy and the public good: evidence for effective interventions
Strang, J., Babor, T., Caulkins, J., Fischer, B., Foxcroft, D., & Humphreys, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61674-7 · Cited by 267
Monoamine transporters and psychostimulant addiction
Howell, L. L., & Kimmel, H. L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.003 · Cited by 255
Metadata
- Authors
- Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 29
- Issue
- 7
- Pages
- 1439-1464
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W2028857574
- Cited by
- 257
- References
- 132
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.